Operating Lease, Right-of-Use Asset of SINOVAC BIOTECH LTD from 31 Dec 2018 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
SINOVAC BIOTECH LTD quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2023.
  • SINOVAC BIOTECH LTD Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2023 was $45,525,000, a 22% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

SINOVAC BIOTECH LTD Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $45,525,000 -$13,061,000 -22% 31 Dec 2023 20-F 29 Apr 2024 2023 FY
Q4 2022 $58,586,000 -$56,790,000 -49% 31 Dec 2022 20-F 29 Apr 2024 2023 FY
Q4 2021 $115,376,000 +$31,543,000 +38% 31 Dec 2021 20-F 01 May 2023 2022 FY
Q4 2020 $83,833,000 +$77,197,000 +1163% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q4 2019 $6,636,000 +$6,636,000 31 Dec 2019 20-F 22 Apr 2021 2020 FY
Q4 2018 $0 31 Dec 2018 20-F 30 Apr 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.